Unum Therapeutics Adds Board Member
This article was originally published in Scrip
Executive Summary
Unum Therapeutics has appointed Jörn Aldag to its board of directors. Aldag is currently chair of Partners AG, Switzerland and until recently, he was CEO of uniQure, a gene therapy company. Prior to this, he was president and CEO of Evotec AG.